Diabetes

Diabetes developments
New technology, more product offerings and better awareness are changing diabetes management.
FDA gives Sanofi-Aventis green light for Novolog biosimilar
Merilog, a rapid-acting human insulin analog, is the first rapid-acting insulin biosimilar product approved by the FDA.

Novo Nordisk to cap insulin prices in Minnesota settlement

Patients will pay no more than $35 a month.
FDA approves new indication for Novo Nordisk’s Ozempic

Ozempic has been approved to reduce the risk of worsening kidney disease and cardiovascular death in adults with Type 2 diabetes and chronic kidney disease.
Hy-Vee dietitians offering 1,500 free biometric screenings in February

Hy-Vee dietitians also will offer additional events throughout the month to support customers’ wellness journeys.
Dexcom debuts GenAI platform in glucose biosensing

The Dexcom GenAI platform analyzes individual health data patterns to reveal a direct association between lifestyle choices and glucose levels.
Owen Mumford releases injection pen training video for healthcare professionals

The video addresses critical steps when clinically administering insulin via injection pens and is beneficial for healthcare providers in long-term care, acute care and alternate care sites.
Dexcom and Ōura announce partnership

The partnership will enable two-way data flow between Dexcom glucose biosensors and the Oura Ring.
Which states have highest obesity, diabetes, heart disease, stroke mortality rates?

West Virginia has the highest prevalence of obesity and highest diabetes rate in the nation.
FDA gives Lupin tentative nod for generic Janumet

Sitagliptin and metformin hydrochloride tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

Diabetes developments

FDA gives Sanofi-Aventis green light for Novolog biosimilar

Novo Nordisk to cap insulin prices in Minnesota settlement

FDA approves new indication for Novo Nordisk’s Ozempic

Hy-Vee dietitians offering 1,500 free biometric screenings in February

Dexcom debuts GenAI platform in glucose biosensing

Owen Mumford releases injection pen training video for healthcare professionals

Dexcom and Ōura announce partnership

Which states have highest obesity, diabetes, heart disease, stroke mortality rates?

FDA gives Lupin tentative nod for generic Janumet